| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2000 | CN1056279C Medicinal composition for prevention and treatment of ischemic cerebral apoplexy and preparation process thereof |
| 09/13/2000 | CN1056277C Preparation process for tablet containing granule structure |
| 09/12/2000 | US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease |
| 09/12/2000 | US6118017 Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one |
| 09/12/2000 | US6118011 Mixture of lipid and taxane |
| 09/12/2000 | US6118006 Method for preparing a tetrahydropyridin derivative |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117998 A1 adenosine receptor antagonists |
| 09/12/2000 | US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening |
| 09/12/2000 | US6117970 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 09/12/2000 | US6117913 Administering creosote or a phenolic derivative of creosote. |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117911 Administration of at least one therapeutic agent that elevates the level of tgf-beta in said mammal. |
| 09/12/2000 | US6117910 Bicyclic fibrinogen antagonists |
| 09/12/2000 | US6117909 Methods of using sulfamic acid derivatives for lowering serum or plasma level of Lp(a) |
| 09/12/2000 | US6117908 Use of GABAB receptor agonists as reflux inhibitors |
| 09/12/2000 | US6117907 Topical treatment of ocular pain after corneal surgery |
| 09/12/2000 | US6117906 GABA and L-glutamic acid analogs for antiseizure treatment |
| 09/12/2000 | US6117904 Treatment of pruritus |
| 09/12/2000 | US6117902 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors |
| 09/12/2000 | US6117901 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use |
| 09/12/2000 | US6117900 Use of retigabine for the treatment of neuropathic pain |
| 09/12/2000 | US6117899 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as its sequelae |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117896 Methods for regulating transcription factors |
| 09/12/2000 | US6117895 Dialkoxyphenyl-substituted oxazolidinones |
| 09/12/2000 | US6117894 Maintains its stability after six months or more of storage. |
| 09/12/2000 | US6117893 Heterocyclic compounds having anti-diabetic activity and their use |
| 09/12/2000 | US6117891 Administering to a patient an effective amount of a pyridine-or pyrimidine-substituted olefin |
| 09/12/2000 | US6117890 Xanomeline |
| 09/12/2000 | US6117889 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
| 09/12/2000 | US6117887 Inhibition of 26S and 20S proteasome by indanones |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | US6117881 N-cinnamoyl derivatives of (β) carbolines |
| 09/12/2000 | US6117880 Treatment of diabetes, retinopathy, restinosis, acromegaly, and depression |
| 09/12/2000 | US6117879 Methods of using moxonidine to inhibit nociceptive pain |
| 09/12/2000 | US6117878 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| 09/12/2000 | US6117877 Method for treating painful conditions of the anal region and compositions therefor |
| 09/12/2000 | US6117875 Prophylactic or therapeutic treatment of phosphodiesterase iv (pde-iv) and tumor necrosis factor (tnf) mediated diseases |
| 09/12/2000 | US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists |
| 09/12/2000 | US6117873 Can be used for the treatment of pathological conditions which respond to blockage of excitatory amino acid receptors |
| 09/12/2000 | US6117872 Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity |
| 09/12/2000 | US6117871 6-(2-imidazolinylamino)quinoxaline compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2000 | US6117868 Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| 09/12/2000 | US6117867 In medicine and veterinary medicine |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/12/2000 | US6117864 Methods employing stable preparation containing azelastine hydrochloride |
| 09/12/2000 | US6117862 Model and method for angiogenesis inhibition |
| 09/12/2000 | US6117861 Protein kinase C inhibitor |
| 09/12/2000 | US6117860 Nasally administering steroid which binds to a specific neuroepithelial receptor for alleviating premenstrual tension and anxiety |
| 09/12/2000 | US6117859 Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides |
| 09/12/2000 | US6117857 Pharmaceutical composition |
| 09/12/2000 | US6117856 Topical bisphosphonates for prevention of bone resorption |
| 09/12/2000 | US6117855 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 09/12/2000 | US6117853 Cerebration improver |
| 09/12/2000 | US6117851 Treating osteoarthritis in mammals comprising administering poly-n-acetyl-d-glucosamine (poly-nag), a pharmaceutically acceptable derivative of poly-nag, and mixtures |
| 09/12/2000 | US6117850 Mobilization of peripheral blood precursor cells by β(1,3)-glucan |
| 09/12/2000 | US6117849 S-(+)-adenosylmethionine and 3'-azido-2', 3'-dideoxy-nucleoside complexes as potent inhibitors of HIV-replication |
| 09/12/2000 | US6117848 Antisense oligonucleotide inhibition of ras |
| 09/12/2000 | US6117846 Nucleic acid filters |
| 09/12/2000 | US6117845 C-linked analogs of N-(4-hydroxyphenyl) retinamide |
| 09/12/2000 | US6117844 Method and composition for antiviral therapy |
| 09/12/2000 | US6117843 Compositions for the treatment of acne containing clindamycin and benzoyl peroxide |
| 09/12/2000 | US6117838 Administering from about 30 to about 1,225 milligrams of intermolecularly- or intramolecularly-crosslinked stroma-free hemoglobin per kilogram of body weight to the mammal |
| 09/12/2000 | US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents |
| 09/12/2000 | US6117475 Fat based food products comprising sterols |
| 09/12/2000 | US6117453 A tablet consists of a drug selected from acyclovir, nifedipine, nicardipine, captopril, verapamil, diltiazem, oxybutynine, valacyclovir, glipizide, felodipine, isosorbide, carbidopa, lavodopa, pentoxiphylline; and polyethylene oxide |
| 09/12/2000 | US6117451 Direct compression metformin hydrochloride tablets |
| 09/12/2000 | US6117447 Percutaneous absorption type preparation |
| 09/12/2000 | US6117446 A buccal dosage unit for administering a combination of steroidal active agents, comprising a compressed tablet of a bioerodible polymeric carrier and an androgenic agent selected from testosterone and esters, progestin and esterogen |
| 09/12/2000 | US6117445 Administration of an a1 adenosine receptor antagonist, or p2x purinoceptor or a compination of both offer potential as an antifibrotic or antisclerotic treatment |
| 09/12/2000 | US6117442 A core comprising androgen as a therapeutical agent and an elastomeric membrane encasing the core comprising polysiloxane containing 3,3,3 trifluoropropylgroup attached to silicon atom of siloxane unit |
| 09/12/2000 | US6117433 Use of compositions comprising stabilized biologically effective compounds |
| 09/12/2000 | US6117429 Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors |
| 09/12/2000 | US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration |
| 09/12/2000 | US6117412 Administering bismuth compound containing additional heavy atom as contrast enhancer; x-rays, magnetic resonance, ultrasound, and scintigraphic imaging |
| 09/12/2000 | US6117365 N-(3,4-dihydroxybenzyl)-3,5-dimethoxy-4-hydroxy-e-cinnamide, for example; use as antioxidants or as free-radical scavengers, in particular in the cosmetic or dermatological fields, and in foods |
| 09/12/2000 | US6117119 Gelatinous body protection article having a therapeutic additive |
| 09/12/2000 | US6116237 Methods of dry powder inhalation |
| 09/12/2000 | CA2212794C Oil in water emulsions containing propofol and edetate |
| 09/12/2000 | CA2203138C Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents |
| 09/12/2000 | CA2159817C Pyrimidine acyclonucleoside derivatives |
| 09/12/2000 | CA2105384C Treatment of addiction to drugs and substances of abuse |
| 09/12/2000 | CA2064476C Podophyllotoxin preparation containing triglycerides |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/12/2000 | CA2020209C Low viscosity, highly concentrated surfactant suspension |
| 09/08/2000 | WO2000052210A2 Methods for targeting rna molecules |
| 09/08/2000 | WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 09/08/2000 | WO2000052198A1 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase |
| 09/08/2000 | WO2000052144A1 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| 09/08/2000 | WO2000052134A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000052122A1 Detergent compositions comprising photobleaching delivery systems |
| 09/08/2000 | WO2000052101A1 A composition comprising a photo-oxidising agent and uses of the agent |
| 09/08/2000 | WO2000052038A1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers |
| 09/08/2000 | WO2000052033A1 Novel cyclic tetrapeptide derivatives and use thereof as drugs |
| 09/08/2000 | WO2000052032A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 09/08/2000 | WO2000052013A2 Thiazoloindolinone compounds |
| 09/08/2000 | WO2000052010A1 Crystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan-8-yl) -6-fluoro -1,4-dihydro -4-oxo -3-quinoline carboxylic acid |
| 09/08/2000 | WO2000052009A1 Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8- diazabicyclo -[4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic |